Top Manufacturing Companies in Boston, MA (89)

Strong Revenue Growth: Net sales increased 15.7% in 2025 to about $6.4B, then rose 15.6% in Q1 2026 and 22.2% in Q2 2026, extending to 13 consecutive quarters of double‑digit growth. Management raised 2026 guidance to 16–17% net‑sales growth on the back of this acceleration.

Profitability: Net income rose 59.9% in 2025, with adjusted EBITDA up 19.4% to roughly $1.14B. In Q2 2026, adjusted net income grew about 29% and adjusted EBITDA ~19%, even as the company navigated mixed margin dynamics.

Market Expansion: International net sales grew 20.8% in 2025 and accelerated 31.6% in Q1 2026 and 36.6% in Q2 2026, with strong results in the UK, Europe, and Latin America. The company is broadening its total addressable market by adding new product categories and entering new geographies.

Product Line Growth: The lineup has broadened from consumer gita/gitamini (including special editions) to the B2B‑focused kilo mobile robot, with continued feature releases like Forward Following, Trips, and next‑generation hybrid navigation. Event showcases at ProMat/MODEX and ongoing marketing within Piaggio indicate multiple active SKUs and iterations.

Innovation-Driven Growth: New capabilities—including Forward Following, Trips, and next‑generation hybrid navigation trained on a large Smart Behaviors dataset—underline sustained investment in the autonomy stack. Trade‑show demos and product updates in 2025–2026 point to an active R&D‑to‑market cadence.

Diversified Revenue Streams: Technology is being applied beyond standalone robots via a 4D‑imaging‑radar Rider Assistance Solution integrated into Piaggio motorcycles and scooters, opening an OEM channel. Maintaining both consumer (gita/gitamini/gitaplus and special editions) and enterprise (kilo) lines further diversifies potential revenue sources.

Strong Revenue Growth: Company reported accelerating revenue growth across 2024–2025 and guided continued double‑digit expansion for 2026. Quarterly updates highlighted broad‑based momentum in both U.S. and international markets.

Strong Market Position & Advantage: Omnipod leads the tubeless/patch‑pump segment and ranked No. 1 in new customer starts in the U.S. and Europe in 2024–2025, reinforcing competitive momentum. First‑to‑market AID clearance for adults with type 2 diabetes and broad CGM integrations bolster positioning.

Market Expansion: International rollouts and expansion into type 2 diabetes materially increased the addressable market and active user base. Added manufacturing capacity in Malaysia supports global demand and cost scaling.

Strong Revenue Growth: Company-reported Q1 2026 results cite sharp year-over-year growth in net new ARR bookings, plus a standout month for new bookings. A steady cadence of new customer additions and expansion deals underscores momentum.

Customer Loyalty & Retention: Disclosures highlight healthy gross revenue retention and net revenue retention above 100% in Q1 2026. Recurring user‑conference activity and ongoing expansions indicate sustained engagement with existing customers.

Strategic Partnerships: Public integrations and alliances with Autodesk, Hexagon, and ECI’s JobBOSS² broaden reach and embed the product in common shop stacks. Listings and collaborations with ProShop, MIE, and Plex reinforce ecosystem placement.

Strong Revenue Growth: Feedback suggests Schneider delivered record annual results, sustained strong organic growth into early 2026, and holds a sizable backlog that provides good visibility. Company commentary ties momentum to Energy Management and data‑center‑related systems.

Strong Market Position & Advantage: Feedback suggests the firm is widely viewed as a leader across energy management, data center power distribution, and grid/digital platforms, reinforced by independent leaderboards and repeated sustainability accolades. Competitive comparisons also cite strengths in service quality, integration, and overall culture versus key peers.

Market Expansion: Feedback suggests the company is actively investing and hiring, with major U.S. capacity expansions and thousands of open roles globally targeted at AI, data centers, and grid modernization. North America shows particularly strong traction alongside growth in other regions.

Strong Market Position & Advantage: Company filings and industry materials indicate leadership in laboratory and industrial balances and prominent positions in product inspection, reinforced by a large installed base and an extensive direct service network. Feedback suggests this entrenched position and portfolio breadth support premium positioning and resilience across end markets.

Resilient & Sustainable Growth: Recent results and guidance point to steady sales and faster EPS growth with a multi‑year track record of expansion even through softer markets. Feedback suggests recurring service revenue and demand tied to automation and digitalization trends underpin ongoing growth.

Innovation-Driven Growth: The company continues to invest in R&D and roll out smart weighing, automation, and software‑enabled solutions (e.g., LabX and smart draft shields). Feedback suggests these innovations strengthen adoption in regulated workflows and industrial processes, supporting future growth.

Strong Market Position & Advantage: MKS is positioned as a leader in several mission-critical niches (e.g., vacuum measurement, RF power/plasma subsystems, and interconnect/packaging chemistries and laser processing) that are embedded across a broad portion of the semiconductor and advanced electronics toolchain. Its role as an enabling-subsystems provider to major wafer-fab equipment OEMs supports defensibility where design-in and process qualification tend to create stickiness.

Strong Revenue Growth: Revenue is depicted as growing year over year through 2025, with commentary indicating a higher quarterly run-rate entering early 2026. Growth is described as led by Semiconductor and Electronics & Packaging segments even as other areas lag.

Future-Ready Strategy: The company narrative emphasizes alignment with AI-driven demand, advanced packaging, and increasing process complexity that should raise the value of precise control and interconnect solutions. Portfolio actions (including exploring divestiture of non-core chemicals and capacity expansion) are framed as steps to sharpen focus and support ongoing growth.

Strong Revenue Growth: Companywide sales are described as increasing year over year, with momentum exiting 2025 and guidance calling for continued expansion into 2026.

Innovation-Driven Growth: Growth is attributed to innovative medicines and new product submissions, with oncology and immunology performance highlighted as key contributors.

Diversified Revenue Streams: The business is positioned around two large segments—Innovative Medicine and MedTech—creating a broader platform that helps offset declines in specific products.

Strong Brand Reputation: Industry recognition as Overall Winner in Circuits Assembly’s Service Excellence Awards in 2024 and 2025 in the >$500M category points to durable strength in quality and service. A long multi‑year run of wins underscores consistent performance in high‑reliability markets.

Market Expansion: Multiple facility openings and expansions across North America and China signal deliberate capacity growth. An increase in site count over recent years reflects an expanding operating footprint.

Strong Revenue Growth: Company disclosures describe revenue rising materially since 2019 alongside acquisitions that broadened capabilities. Participation in the >$500M category and inclusion in global Top‑50 rankings indicate meaningful scale.

Strong Market Position & Advantage: Disclosures highlight top-tier positions in surgical CO2 lasers and high-performance scanning heads, supported by deep IP, regulatory expertise, and close OEM partnerships. This positioning indicates durable competitive advantages in medical and advanced industrial niches.

Profitability: Adjusted profitability remains strong, with margins in the low-20s and expanding adjusted EBITDA underscoring earnings quality relative to many peers. The portfolio mix is tilting toward higher‑margin medical and microelectronics applications, supporting sustained margin strength.

Future-Ready Strategy: Management has repositioned from niche scanning to integrated subsystems for advanced surgery and robotics, while exiting lower‑margin industrial lines. Momentum in AI‑driven industrial markets, robotics, and advanced surgery is cited as a driver of upcoming organic growth.